TC
FURX

TFS Capital’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

TFS Capital’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-40,061
Closed -$1.36M – 1813
2013
Q2 		$1.36M Buy
+40,061
New +$1.41M 0.06% 472

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MCM
Montibus Capital Management Portland, Oregon $926M AUM

TFS Capital's FURX Position: Q3 2013 in Review

TFS Capital sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2013, closing a stake of 40,061 shares — an estimated $1.36M sold.

TFS Capital first reported a position in FURX in Q2 2013 and held it in 1 quarter. The position peaked at $1.36M in Q2 2013. 85 funds tracked by Wall St. Rank hold FURX as of Q3 2013.

  • TFS Capital reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • TFS Capital sold 40,061 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2013, an estimated $1.36M.
  • TFS Capital first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • TFS Capital's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.36M in Q2 2013.
  • 85 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2013.

Based on TFS Capital's 13F filing for Q3 2013, filed 5 Nov 2013.